What does a herpes simplex virus type 2 (HSV‑2) IgG index of 9 indicate, and how should an asymptomatic patient be managed?

HSV-2 IgG Index of 9: Interpretation and Management

An HSV-2 IgG index value of 9 indicates a true positive result with high confidence, and this asymptomatic patient should be counseled about their chronic HSV-2 infection, transmission risks, and offered suppressive antiviral therapy if they wish to reduce transmission to sexual partners.

Understanding the Index Value

An index value of 9 is well above the critical threshold of 3.0, which is the key cutoff for diagnostic confidence. According to the 2022 CDC guidelines, index values ≥3.0 are sufficient for diagnosis of HSV-2 infection without further confirmatory testing 1. Here's why this matters:

• Index values of 1.1-2.9 have only 39.8% specificity (high false-positive rate)
• Index values ≥3.0 have 78.6% specificity
• Your patient's index of 9 far exceeds this threshold, making false positivity extremely unlikely

While false positives have been described even at index values >3.5, these are rare exceptions 1. At an index of 9, you can confidently diagnose HSV-2 infection without additional confirmatory testing like Western blot or Biokit assay.

Clinical Significance in Asymptomatic Patients

This patient has chronic HSV-2 infection, which is lifelong. The fact that they are asymptomatic is actually typical—most people with HSV-2 infection are asymptomatic or have unrecognized infection 2. This doesn't mean they cannot transmit the virus; asymptomatic viral shedding is a well-documented phenomenon and a major driver of HSV-2 transmission.

Management Approach

Immediate Counseling Points

Provide the following information to your patient:

• They have a chronic, lifelong HSV-2 infection that cannot be cured
• They can transmit the virus to sexual partners even without symptoms
• The annual transmission risk to an uninfected partner is approximately 10% in heterosexual couples without intervention 3
• Condom use and disclosure to partners are essential for reducing transmission risk

Treatment Options

Offer suppressive antiviral therapy, particularly if:

• The patient has a sexual partner who is HSV-2 negative
• The patient wants to reduce transmission risk
• The patient develops symptoms in the future

The three FDA-approved antivirals (acyclovir, famciclovir, valacyclovir) are equally effective. Prioritize once or twice-daily dosing regimens for better adherence 1:

• Valacyclovir 500 mg once daily (most convenient)
• Famciclovir 250 mg twice daily
• Acyclovir 400 mg twice daily

Partner Management

• Recommend that sexual partners be tested for HSV-2 IgG
• If partners are HSV-2 negative, strongly recommend suppressive therapy to reduce transmission
• Counsel about safe sex practices

Common Pitfalls to Avoid

Do not:

• Retest the serology—the diagnosis is established
• Order confirmatory testing at this index value—it's unnecessary and wastes resources
• Assume the patient will develop symptoms—many never do
• Dismiss the diagnosis because the patient is asymptomatic

Do:

• Document this as a chronic infection in the medical record
• Provide written educational materials about HSV-2
• Offer ongoing support and answer questions about transmission
• Screen for other sexually transmitted infections if not recently done

Quality of Life Considerations

HSV-2 diagnosis can significantly impact psychological well-being and sexual health. Address the stigma directly, normalize the diagnosis (it affects over 12% of Americans), and emphasize that with proper management and disclosure, patients can have healthy sexual relationships 4. The goal is preventing transmission to partners and managing any future symptoms, not "curing" an incurable infection.